Clinical OMICS

MAY-JUN 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 49 of 51 May/June 2018 Clinical OMICs 48 Industry Events Biomarkers and Immuno-Oncology World Congress June 11–13, Boston Now in its 14th year, the Biomarkers and Immuno-Oncology World Congress is the annual meeting of choice for those dedicated to biomarkers, diagnostics, and immuno-on- cology research and implementation. The congress brings together a mix of large and medium pharmaceutical, bio- tech, and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies, and tool providers. Join more than 400 attendees to browse the exhibits and for an agenda that includes sessions covering: clinical and translational biomarkers, immuno-oncology biomarkers, combination immunotherapy, biomarkers for patient selection, intrinsic and acquired resistance to immunotherapy, and digital bio- markers encompassing wearables, biosensors and mHealth. Molecular Diagnostics July 9–10, London The SMi group will convene the 5th Molecular Diagnostics Conference amid significant growth in molecular diagnos- tics market that is forecast to reach more than $10 billion in the next three years. The conference features presenta- tions to help attendees say up to date with emerging diag- nostics technologies and their applications, as well as how to manage within the challenging to evolving regulatory landscape. Other themes at this year 's event include: per- sonalized medicine and pharmacogenomics, point-of-care diagnostic methods, and molecular diagnostics for infec- tious diseases and cancer. Sessions of note include "Cancer Research UK's strategy in early detection research—pre- cision diagnostics to precision intervention" by CRUK's, head of early detection research David Crosby; and "Sys- tem's Approach to Immune monitoring—A path towards establishing genetic and microbial determinants of human immune variability" by Matthew Albert, principal scientist, cancer immunology, Genetech. Olyzel / Getty Images AACC Annual Scientific Meeting & Clinical Lab Expo San Diego, July 29–August 2 Join more than 20,000 healthcare leaders at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo to see the newest technologies and learn techniques for medical test- ing to allow patients to receive the highest quality of care. Network with attendees and presenters representing the disciplines of clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of emerging science in laboratory medicine. This year 's meeting features more than 200 educational oppor- tunities in the form of lectures, plenary sessions, symposia, short courses, and roundtable sessions, and the exposition hall will show products and services from more than 750 participating companies. Next Generation Diagnostics Summit August 14–16, Washington, DC Now in its tenth year, the Next Generation Dx Summit attracts more than 1,000 international diagnostic profession- als providing insight to this growing field. As the market demands faster and more precise diagnostics, and regu- latory and reimbursement conditions continue to evolve, the conference provides opportunities for diagnostic pro- fessionals to build partnerships, gain industry knowledge, and network with and learn from their peers. The summit provides a venue to advance the science of diagnostics and improve the practice of medicine. Sessions this year span cell- and cell-free biopsies, commercialization, reimbursement, bio- markers and companion diagnostics for immunotherapy, point-of-care testing, infectious disease, microfluidics and precision medicine.

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAY-JUN 2018